Quick Answer
Beta Bionics, Inc. reported Operating Income of -$71.68 million for fiscal year 2025.
Beta Bionics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$71.68M | -58.4% |
| 2024 | -$45.25M | -26.2% |
| 2023 | -$35.85M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$17.04M | -55.3% | +14.2% |
| June 30, 2025 | -$19.87M | -68.6% | -6.6% |
| March 31, 2025 | -$18.64M | -97.2% | -69.8% |
| September 30, 2024 | -$10.98M | — | +6.8% |
| June 30, 2024 | -$11.78M | — | -24.7% |
| March 31, 2024 | -$9.45M | — | — |
- Beta Bionics, Inc. showed a decrease of -58.4% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, Beta Bionics, Inc.’s operating income has declined by 99.9% (from -$35.85 million to -$71.68 million).
- The most recent figure is from Beta Bionics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: